313 related articles for article (PubMed ID: 21167132)
1. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.
Shin KH; Bae SD; Hong HS; Kim RH; Kang MK; Park NH
Biochem Biophys Res Commun; 2011 Jan; 404(4):896-902. PubMed ID: 21167132
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
3. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
[TBL] [Abstract][Full Text] [Related]
4. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
Chang KW; Chu TH; Gong NR; Chiang WF; Yang CC; Liu CJ; Wu CH; Lin SC
Oral Dis; 2013 Sep; 19(6):611-9. PubMed ID: 23231387
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
Yang X; Wu H; Ling T
Mol Med Rep; 2014 Jul; 10(1):125-30. PubMed ID: 24789258
[TBL] [Abstract][Full Text] [Related]
6. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
7. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
[TBL] [Abstract][Full Text] [Related]
8. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras.
Tsang WP; Kwok TT
Carcinogenesis; 2009 Jun; 30(6):953-9. PubMed ID: 19372139
[TBL] [Abstract][Full Text] [Related]
9. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.
Chang KW; Kao SY; Wu YH; Tsai MM; Tu HF; Liu CJ; Lui MT; Lin SC
Oral Oncol; 2013 Jan; 49(1):27-33. PubMed ID: 22854067
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
11. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
Du Y; Li Y; Lv H; Zhou S; Sun Z; Wang M
Int J Clin Exp Pathol; 2015; 8(10):12252-9. PubMed ID: 26722410
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
Uesugi A; Kozaki K; Tsuruta T; Furuta M; Morita K; Imoto I; Omura K; Inazawa J
Cancer Res; 2011 Sep; 71(17):5765-78. PubMed ID: 21795477
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.
Wang X; Li GH
J Cell Physiol; 2018 Dec; 233(12):9447-9457. PubMed ID: 30136280
[TBL] [Abstract][Full Text] [Related]
15. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
Chi H
Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
[TBL] [Abstract][Full Text] [Related]
17. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
18. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
Zhang D; Ni Z; Xu X; Xiao J
Med Sci Monit; 2014 Dec; 20():2527-35. PubMed ID: 25472588
[TBL] [Abstract][Full Text] [Related]
19. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
Wang X; Li F; Zhou X
Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
[TBL] [Abstract][Full Text] [Related]
20. miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.
Neu J; Dziunycz PJ; Dzung A; Lefort K; Falke M; Denzler R; Freiberger SN; Iotzova-Weiss G; Kuzmanov A; Levesque MP; Dotto GP; Hofbauer GFL
PLoS One; 2017; 12(9):e0185028. PubMed ID: 28931048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
